COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
Description
CONCLUSION: Variable seropositive rates are seen in patients with plasma cell dyscrasia. Lower rates are reported in patients on active therapy, anti-CD38 therapy, and elderly patients. Hence, we propose patients with plasma cell dyscrasias should
